Targeting the prostate for destruction through a vascular address
AUTOR(ES)
Arap, Wadih
FONTE
The National Academy of Sciences
RESUMO
Organ specific drug targeting was explored in mice as a possible alternative to surgery to treat prostate diseases. Peptides that specifically recognize the vasculature in the prostate were identified from phage-displayed peptide libraries by selecting for phage capable of homing into the prostate after an i.v. injection. One of the phage selected in this manner homed to the prostate 10–15 times more than to other organs. Unselected phage did not show this preference. The phage bound also to vasculature in the human prostate. The peptide displayed by the prostate-homing phage, SMSIARL (single letter code), was synthesized and shown to inhibit the homing of the phage when co-injected into mice with the phage. Systemic treatment of mice with a chimeric peptide consisting of the SMSIARL homing peptide, linked to a proapoptotic peptide that disrupts mitochondrial membranes, caused tissue destruction in the prostate, but not in other organs. The chimeric peptide delayed the development of the cancers in prostate cancer-prone transgenic mice (TRAMP mice). These results suggest that it may be possible to develop an alternative to surgical prostate resection and that such a treatment may also reduce future cancer risk.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=122224Documentos Relacionados
- Targeting rheumatoid inflammation and joint destruction in the mouse
- Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.
- Comparison of two peptide radiotracers for prostate carcinoma targeting
- Image-guided percutaneous targeting of lymph nodes: a novel approach for salvage pelvic lymphadenectomy in recurrent prostate cancer
- The mitochondrial ARTS protein promotes apoptosis through targeting XIAP